Sobrevida de pacientes com ferida neoplásica maligna atendidos em um Câncer Center

Detalhes bibliográficos
Autor(a) principal: Costa, Sabrina dos Santos Pinho
Data de Publicação: 2023
Outros Autores: Matsubara, Maria das Graças Silva
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/43280
Resumo: Objective: To evaluate the survival of patients with malignant neoplastic wound treated at a Cancer Center. Method: This is an observational, retrospective and descriptive cohort study, with a quantitative approach, using secondary data extracted from medical records of patients diagnosed with cancer who had a malignant neoplastic wound. Data collection was carried out between 2018 and 2020. For the analysis of quantitative variables, absolute and relative frequencies were considered. To determine the probability of survival, the Kaplan-Meier estimator was used. The log-rank test was used to determine the existence of differences between the survival curves. Results and discussion: The sample consisted of 118 patients. Among the participants, the majority were women, white, married, aged over 60 years, who had completed higher education, attended by the health insurance. There was a predominance of patients diagnosed with breast and head and neck cancer, with advanced staging. The mean overall survival of the sample was 10 months. The probability of overall survival at 1 year was 20%, and at 2 years it was 9%. Smoking history was statistically significant (p=0.05), showing that participants who never smoked had a longer overall survival. The treatment scheme was statistically significant (p=0.005), showing that participants who received the combination of radiotherapy and chemotherapy had a longer survival. Conclusion: The overall survival of patients with a malignant neoplastic wound was eight months, with worse results for patients with a history of smoking and better results for combined treatments.
id UNIFEI_3e81ccc0cbe97508eeb1673af823f3fd
oai_identifier_str oai:ojs.pkp.sfu.ca:article/43280
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Sobrevida de pacientes com ferida neoplásica maligna atendidos em um Câncer Center Survival of patients with malignant neoplastic wound served at a Cancer Center Supervivencia de pacientes con herida neoplasica maligna servido en un Centro de CáncerOncologiaNeoplasiasAnálisis de supervivenciaHeridas y lesionesCuidados paliativos.Análise de sobrevidaOncologiaNeoplasiasFerimentos e lesõesCuidados paliativos. OncologyNeoplasmsSurvival analysisWounds and injuriesPalliative care.Objective: To evaluate the survival of patients with malignant neoplastic wound treated at a Cancer Center. Method: This is an observational, retrospective and descriptive cohort study, with a quantitative approach, using secondary data extracted from medical records of patients diagnosed with cancer who had a malignant neoplastic wound. Data collection was carried out between 2018 and 2020. For the analysis of quantitative variables, absolute and relative frequencies were considered. To determine the probability of survival, the Kaplan-Meier estimator was used. The log-rank test was used to determine the existence of differences between the survival curves. Results and discussion: The sample consisted of 118 patients. Among the participants, the majority were women, white, married, aged over 60 years, who had completed higher education, attended by the health insurance. There was a predominance of patients diagnosed with breast and head and neck cancer, with advanced staging. The mean overall survival of the sample was 10 months. The probability of overall survival at 1 year was 20%, and at 2 years it was 9%. Smoking history was statistically significant (p=0.05), showing that participants who never smoked had a longer overall survival. The treatment scheme was statistically significant (p=0.005), showing that participants who received the combination of radiotherapy and chemotherapy had a longer survival. Conclusion: The overall survival of patients with a malignant neoplastic wound was eight months, with worse results for patients with a history of smoking and better results for combined treatments.Objetivo: Avaliar a sobrevida de pacientes com ferida neoplásica maligna atendidos em um Cancer Center. Método: Trata-se de um estudo de coorte observacional, retrospectivo e descritivo, com abordagem quantitativa, utilizando dados secundários extraídos de prontuários de pacientes com diagnóstico de câncer que possuíam ferida neoplásica maligna. A coleta de dados perfez o período entre 2018 e 2020. Para a análise das variáveis quantitativas foram consideradas as frequências absolutas e relativas. Para determinar a probabilidade de sobrevida, foi aplicado o estimador de Kaplan-Meier. O teste de log-rank foi utilizado para determinar a existência de diferenças entre as curvas de sobrevida. Resultados e Discussão: A amostra foi composta por 118 pacientes. Dentre os participantes, a maioria eram mulheres, de cor branca, casadas, com idade maior que 60 anos, que possuíam ensino superior completo, atendidas pelo convênio. Predominou pacientes com diagnóstico câncer de mama e cabeça e pescoço, com estadiamento avançado. A sobrevida global média foi de 10 meses. A probabilidade de sobrevida global em um ano foi de 20%, e em dois anos foi de 9%. A história de tabagismo foi estatisticamente significante (p=0,05), mostrando que os participantes que nunca fumaram possuíam uma maior sobrevida global. O esquema de tratamento foi estatisticamente significante (p=0,005), mostrando que os participantes que fizeram a combinação de radioterapia e quimioterapia possuíam uma sobrevida maior. Conclusão: A sobrevida global dos pacientes com ferida neoplásica maligna foi de dez meses, com piores resultados para pacientes com histórico de tabagismo e melhores para tratamentos combinados.Objetivo: Evaluar la sobrevida de pacientes con herida neoplásica maligna atendidos en un Centro Oncológico. Método: Se trata de un estudio de cohortes observacional, retrospectivo y descriptivo, con enfoque cuantitativo, utilizando datos secundarios extraídos de las historias clínicas de pacientes diagnosticados de cáncer que presentaban una herida neoplásica maligna. La recolección de datos se realizó entre 2018 y 2020. Para el análisis de las variables cuantitativas se consideraron frecuencias absolutas y relativas. Para determinar la probabilidad de supervivencia se utilizó el estimador de Kaplan-Meier. Se utilizó la prueba de rangos logarítmicos para determinar la existencia de diferencias entre las curvas de supervivencia. Resultados y Discusión: La muestra estuvo conformada por 118 pacientes. Entre los participantes, la mayoría eran mujeres, blancas, casadas, mayores de 60 años, con estudios superiores concluidos, atendidas por el seguro de salud. Hubo un predominio de pacientes con diagnóstico de cáncer de mama y de cabeza y cuello, con estadificación avanzada. La supervivencia global media de la muestra fue de 10 meses. La probabilidad de supervivencia global a 1 año fue del 20% ya los 2 años del 9%. El historial de tabaquismo fue estadísticamente significativo (p = 0,05), lo que muestra que los participantes que nunca fumaron tuvieron una supervivencia general más prolongada. El esquema de tratamiento fue estadísticamente significativo (p=0,005), demostrando que los participantes que recibieron la combinación de radioterapia y quimioterapia tuvieron una mayor supervivencia. Conclusión: La supervivencia global de los pacientes con herida neoplásica maligna fue de ocho meses, con peores resultados para los pacientes con antecedente de tabaquismo y mejores resultados para los tratamientos combinados.Research, Society and Development2023-09-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4328010.33448/rsd-v12i9.43280Research, Society and Development; Vol. 12 No. 9; e11712943280Research, Society and Development; Vol. 12 Núm. 9; e11712943280Research, Society and Development; v. 12 n. 9; e117129432802525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/43280/34866Copyright (c) 2023 Sabrina dos Santos Pinho Costa; Maria das Graças Silva Matsubarahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCosta, Sabrina dos Santos Pinho Matsubara, Maria das Graças Silva 2023-10-01T10:43:32Zoai:ojs.pkp.sfu.ca:article/43280Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2023-10-01T10:43:32Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Sobrevida de pacientes com ferida neoplásica maligna atendidos em um Câncer Center
Survival of patients with malignant neoplastic wound served at a Cancer Center
Supervivencia de pacientes con herida neoplasica maligna servido en un Centro de Cáncer
title Sobrevida de pacientes com ferida neoplásica maligna atendidos em um Câncer Center
spellingShingle Sobrevida de pacientes com ferida neoplásica maligna atendidos em um Câncer Center
Costa, Sabrina dos Santos Pinho
Oncologia
Neoplasias
Análisis de supervivencia
Heridas y lesiones
Cuidados paliativos.
Análise de sobrevida
Oncologia
Neoplasias
Ferimentos e lesões
Cuidados paliativos.
Oncology
Neoplasms
Survival analysis
Wounds and injuries
Palliative care.
title_short Sobrevida de pacientes com ferida neoplásica maligna atendidos em um Câncer Center
title_full Sobrevida de pacientes com ferida neoplásica maligna atendidos em um Câncer Center
title_fullStr Sobrevida de pacientes com ferida neoplásica maligna atendidos em um Câncer Center
title_full_unstemmed Sobrevida de pacientes com ferida neoplásica maligna atendidos em um Câncer Center
title_sort Sobrevida de pacientes com ferida neoplásica maligna atendidos em um Câncer Center
author Costa, Sabrina dos Santos Pinho
author_facet Costa, Sabrina dos Santos Pinho
Matsubara, Maria das Graças Silva
author_role author
author2 Matsubara, Maria das Graças Silva
author2_role author
dc.contributor.author.fl_str_mv Costa, Sabrina dos Santos Pinho
Matsubara, Maria das Graças Silva
dc.subject.por.fl_str_mv Oncologia
Neoplasias
Análisis de supervivencia
Heridas y lesiones
Cuidados paliativos.
Análise de sobrevida
Oncologia
Neoplasias
Ferimentos e lesões
Cuidados paliativos.
Oncology
Neoplasms
Survival analysis
Wounds and injuries
Palliative care.
topic Oncologia
Neoplasias
Análisis de supervivencia
Heridas y lesiones
Cuidados paliativos.
Análise de sobrevida
Oncologia
Neoplasias
Ferimentos e lesões
Cuidados paliativos.
Oncology
Neoplasms
Survival analysis
Wounds and injuries
Palliative care.
description Objective: To evaluate the survival of patients with malignant neoplastic wound treated at a Cancer Center. Method: This is an observational, retrospective and descriptive cohort study, with a quantitative approach, using secondary data extracted from medical records of patients diagnosed with cancer who had a malignant neoplastic wound. Data collection was carried out between 2018 and 2020. For the analysis of quantitative variables, absolute and relative frequencies were considered. To determine the probability of survival, the Kaplan-Meier estimator was used. The log-rank test was used to determine the existence of differences between the survival curves. Results and discussion: The sample consisted of 118 patients. Among the participants, the majority were women, white, married, aged over 60 years, who had completed higher education, attended by the health insurance. There was a predominance of patients diagnosed with breast and head and neck cancer, with advanced staging. The mean overall survival of the sample was 10 months. The probability of overall survival at 1 year was 20%, and at 2 years it was 9%. Smoking history was statistically significant (p=0.05), showing that participants who never smoked had a longer overall survival. The treatment scheme was statistically significant (p=0.005), showing that participants who received the combination of radiotherapy and chemotherapy had a longer survival. Conclusion: The overall survival of patients with a malignant neoplastic wound was eight months, with worse results for patients with a history of smoking and better results for combined treatments.
publishDate 2023
dc.date.none.fl_str_mv 2023-09-24
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/43280
10.33448/rsd-v12i9.43280
url https://rsdjournal.org/index.php/rsd/article/view/43280
identifier_str_mv 10.33448/rsd-v12i9.43280
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/43280/34866
dc.rights.driver.fl_str_mv Copyright (c) 2023 Sabrina dos Santos Pinho Costa; Maria das Graças Silva Matsubara
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Sabrina dos Santos Pinho Costa; Maria das Graças Silva Matsubara
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 12 No. 9; e11712943280
Research, Society and Development; Vol. 12 Núm. 9; e11712943280
Research, Society and Development; v. 12 n. 9; e11712943280
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052630882582528